What you should know:
1. Bausch Health, which was known as Valeant Pharmaceuticals during the aforementioned time period, allegedly defrauded investors in financial statements by covering up ties with mail-order pharmacy company Philidor Rx, MarketWatch reports.
2. Bausch settled all charges without admitting guilt or denying the SEC’s charges.
3. The SEC recognized Bausch’s efforts to conduct an investigation into the matter and provide information voluntarily to SEC staff.
4. Since the incident, Bausch rebranded the company and installed a new board and executive management team.
More articles on specialty centers:
ASC considers in-house alternative to ‘overwhelmed’ hospital testing center — 3 insights
425 surgery centers that received PPP funds of more than $150K by state
4 COVID-19 testing insights for ASCs
